Novartis and Bayer seek to oppose High Court ruling over NHS decision to use cheaper drug
October 16, 2018Manufacturing and Production Bayer, CCG, NHS, Novartis, avastin, wet AMD
Swiss multinational Novartis have joined German pharma firm Bayer in appealing a High Court ruling over 12 NHS clinical commissioning …
Trump administration propose ruling requiring price transparency on TV ads
October 16, 2018Manufacturing and Production Alex Azar, Drug pricing, Trump, access, adverts
US Health and Human Services Secretary Alex Azar, has announced a proposal which would require pharma firms to include the …
Amgen launches first biosimilar of best-selling Humira in Europe
October 16, 2018Manufacturing and Production, Sales and Marketing Amgen, Amgevita, Humira, biosimilar, pharma
Amgen has announced the launch of a proprietary biosimilar version of Abbvie’s best-selling drug Humira (adalimumab) across all European markets, …
AstraZeneca halting UK investment due to Brexit uncertainty
October 15, 2018Manufacturing and Production AstraZeneca, Le Monde, UK, brexit, no-deal
The Anglo-Swedish pharma firm AstraZeneca has suspended investment into the United Kingdom, due to the uncertainty surrounding Brexit. The firm’s …
MSD and Samsung Bioepis terminate development of Lantus biosimilar for diabetes
October 15, 2018Research and Development, Sales and Marketing Lantus, MSD, Samsung Bioepis, Sanofi, biosimilar, diabetes, pharma
MSD has reportedly terminated a previous agreement with Samsung Bioepis which would have seen them collaborate on a biosimilar version …
AI, big data: Making a case for faster drug discovery
October 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Big Data, feature, healthcare, research
They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI …
FDA advisory panel approves AcelRx’s opioid pain drug Dsuvia
October 15, 2018Sales and Marketing FDA, approval, comittee, opioids
An FDA advisory panel voted 10 to 3 to recommend the approval of AcelRx Pharmaceuticals’ opioid pain drug Dsuvia (sufentanil) …
Digital system may prevent £300m prescription fraud losses for NHS by 2020
October 15, 2018Sales and Marketing NHS, fraud, government, prescription fraud, uk politics
The British government are launching a new digitised system aimed at cracking down on prescription fraud in the NHS. However …
BMS’ Opdivo fails to improve overall survival in small-cell lung cancer
October 15, 2018Research and Development, Sales and Marketing BMS< Opdivo, Bristol-Myers Squibb, Cancer, lung cancer, pharma
Bristol-Myers Squibb’s Opdivo (nivolumab) failed to deliver on its primary endpoint in a Phase 3 study in small-cell lung cancer, …
Health innovation system is broken and failing patients, new report argues
October 15, 2018Sales and Marketing IP, industry, intellectual property, priofit, research
The pharmaceutical industry is incentivised to set high prices and deliver short-term returns to shareholders, rather than focusing on riskier, …
Novo Nordisk’s Fiasp shows strong blood sugar control in under-18 type 1 diabetes patients
October 12, 2018Medical Communications, Research and Development Fiasp, Novo Nordisk, Type 1 diabetes, diabetes, pharma
New data unveiled by Novo Nordisk has shown that its insulin injection Fiasp (fast-acting insulin aspart) could provide a better …
Top Ten most popular articles on Pharmafile.com this week
October 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, biosimilars. GSK, manufacturing, pharma, top 10
Politics played a big role in pharma this week after Trump introduced legislation aimed at reducing the price of drugs. …
Trevena’s opioid injection fails to win over FDA committee
October 12, 2018Medical Communications, Sales and Marketing FDA, Trevena, US, oliceridine, opioid, opioid crisis, pharma
Trevena has seen its opioid injection oliceridine fail to win over an FDA advisory panel in the management of acute …
Chanelle Pharma announces €86m investment over next five years
October 12, 2018Medical Communications Ireland, chanelle, generics, investment, research
Chanelle Pharmaceuticals, one of the largest Irish-owned pharmaceutical companies in Ireland, have announced an €86 million investment programme over the …
USA struggles and middle income countries could do more in tackling health inequality according to Oxfam report
October 12, 2018Medical Communications Latin America, USA, health, inequality, oxfam
A cluster of Latin American countries such as Costa Rica, Uruguay and Argentina, and a cluster of OECD countries with …
Living with Langerhans Cell Histiocytosis
October 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Langerhans Cell Histiocytosis, feature. pharma, patient experience, rare diseae
Affected as a young child by a rare disease which targets just one in 200,000 and led to neurodegeneration throughout …
Roche’s Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS
October 11, 2018Research and Development Ocrevus, Roche, multiple sclerosis, pharma
Roche has unveiled new five-year data from three Phase 3 open-label extension studies investigating the efficacy of Ocrevus (ocrelizumab) in …
New US trade policy may limit foreign investment into biotechs
October 11, 2018Research and Development CIFUS, Trump, america, biotech, capital, foreign investment
The US Trump Administration have issued new rules, which will put foreign investment into companies involved in the development and …
Sequiris invest £40m into expansion of Liverpool plant creating 100 new jobs
October 11, 2018Manufacturing and Production, Research and Development Jobs, Vaccine, investment, liverpool
The Liverpool-based vaccine-maker Sequiris is investing £40 million into the expansion of its operations in the Speke area of Liverpool. …
Celltrion’s Rituxan biosimilar gets unanimous backing from FDA committee
October 11, 2018Sales and Marketing FDA, Oncologic Drugs Advisory Committee, Rituxan, Roche, Truxima
FDA approval looks to be in reach for Celltrion, as an advisory committee for the US regulator voted unanimously to …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
